Sudarshan Chemical Industries (506655) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
9 Sep, 2026Executive summary
Achieved strong profitability momentum in Q1 FY27, with significant improvements in EBITDA and net debt reduction compared to previous periods.
Unaudited standalone and consolidated financial results for the quarter ended 30th June 2026 were approved, showing strong revenue and profit growth year-over-year.
Integration of acquired group progressing, with unified culture, leadership hires, and SAP implementation underway.
In-principle approval was granted for internal restructuring via acquisition of a 70.26% stake in a step-down subsidiary, Sudarshan Colorants India Limited, to be held directly.
Maintained global leadership in pigments, serving over 4,000 customers in 100+ countries with a robust product portfolio.
Financial highlights
Q1 FY27 consolidated revenue from operations was ₹2,642.1 crore, up from ₹2,506.9 crore in Q1 FY26, a 5.4% year-over-year increase.
Business EBITDA for Q1 FY27 reached ₹247 crore, a 63% increase year-over-year; reported EBITDA was ₹266 crore, up 61.4%.
Consolidated net profit for Q1 FY27 was ₹103.4 crore, up from ₹55.0 crore in Q1 FY26.
Net debt reduced to ₹531 crore from a peak of ₹922 crore as of September 2025.
Earnings per share for Q1 FY27 was ₹12.3, up from ₹6.0 in Q1 FY26.
Outlook and guidance
FY27 guidance for acquired group reaffirmed: sales of ~€700 Mn and EBITDA of ~€35 Mn.
Continued focus on integration, value capture, and working capital efficiency.
Cautious approach to market volatility due to geopolitical and macroeconomic uncertainties.
No explicit forward-looking guidance provided, but internal restructuring and integration costs indicate ongoing transformation and focus on operational efficiency.
Latest events from Sudarshan Chemical Industries
- Revenue and margins rose, with normalized profit and improved financial strength.506655
Q1 24/25 - Acquisition creates a global pigment leader with 19 sites and accretive financials.506655
M&A announcement - Record revenue and profit growth, margin expansion, and major global acquisition approved.506655
Q2 24/25 - Record revenue and profit growth in Q3/9M FY25, with strong pigment exports and acquisition-driven expansion.506655
Q3 24/25 - Heubach acquisition drove strong revenue and EBITDA growth, but net profit declined on costs.506655
Q4 24/25 - Q1 FY26 sales reached ₹2,507 Cr and EBITDA rose, but margins and net profit ratio declined.506655
Q1 25/26 - Pigments-led growth and Heubach acquisition drove higher revenue, with integration costs impacting profit.506655
Q2 25/26 - Revenue growth from acquisition offset by integration and regulatory costs, resulting in a net loss.506655
Q3 25/26 - Record revenue and EBITDA growth achieved, with Heubach integration and debt reduction progressing.506655
Q4 25/26